3rd Pharma Company Announces Anti-Viral Drug To Treat COVID-19 Patients In India
Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold in the market under the brand name of Cipremi, this one is a generic version of antiviral drug Remdesivir to be used in…